Business
NEUPATH HEALTH REPORTS FOURTH QUARTER AND YEAR-END 2025 RESULTS
Fourth quarter total revenue of $22.1 million, up 17% year-over-year Positive cash flows,...
About this update from Neupath Health Inc.
[{"type":"text","content":"NEUPATH HEALTH REPORTS FOURTH QUARTER AND YEAR-END 2025 RESULTS\n\n\n .bwalignc { text-align: center; list-style-position: inside }\n.bwalignl { text-align: left }\n.bwalignr { text-align: right; list-style-position: inside }\n.bwblockalignl { margin-left: 0px; margin-right: auto }\n.bwcellpmargin { margin-bottom: 0px; margin-top: 0px }\n.bwlistdisc { list-style-type: disc }\n.bwnowrap { white-space: nowrap }\n.bwpadb3 { padding-bottom: 4px }\n.bwpadl0 { padding-left: 0px }\n.bwpadl20 { padding-left: 100px }\n.bwpadl6 { padding-left: 30px }\n.bwpadr0 { padding-right: 0px }\n.bwsinglebottom { border-bottom: solid black 1pt }\n.bwtablemarginb { margin-bottom: 10px }\n.bwtopsingle { border-top: solid black 1pt }\n.bwvertalignb { vertical-align: bottom }\n.bwvertalignt { vertical-align: top }\n.bwwidth100 { width: 100% }\n.bwwidth12 { width: 12% }\n.bwwidth52 { width: 52% }\n.bwwidth76 { width: 76% }\n \n\n\n\n\n\n Fourth quarter total revenue of $22.1 million, up 17% year-over-year\n \n\n\n\n Positive cash flows, with Adjusted EBITDA\n \n (1)\n \n of $1.0 million, up 9% year-over-year, and our 28\n \n th\n \n consecutive quarter of positive Adjusted EBITDA\n \n\n\n\n Investor webinar scheduled for Thursday, March 26, 2026 at 10:00 AM ET / 7:00 AM PT\n \n\n\n\n\n\n NeuPath Health Inc. (TSXV:NPTH), (“NeuPath” or the “Company”) operates one of Canada’s largest networks of community-based, multidisciplinary medical facilities focused on the assessment and treatment of chronic pain, musculoskeletal/back pain, sports medicine and other pain medical services markets, today announced its financial and operating results for the three months and year ended December 31, 2025, the grant of stock options (“Options”) and restricted share units (“RSUs”) and information regarding the Company’s investor webinar on Thursday, March 26, 2026. All figures are in Canadian dollars, unless otherwise noted.\n \n\n “The team delivered another successful year, generating strong operating results in 2025 by serving more patients and introducing new services for Canadian patients,” said Joe Walewicz, NeuPath’s Chief Executive Officer. “We entered 2026 in a very strong position, and I look forward to Stephen and the entire NeuPath team executing on our growth strat...